Funding · Company
Curevo, Inc.
Seattle, WABiotech & Pharma
Curevo, Inc. of Seattle, WA has disclosed $110M across 3 Form D offerings filed with the SEC between Jan 12, 2022 and Mar 18, 2025.
$110M
Total disclosed
3
Form D offerings
2021
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$42M
Form D · Mar 18, 2025 ↗
Q1 2025
· target $85M
$22M
Form D · Nov 21, 2022 ↗
Q4 2022
· target $26M
$46M
Form D · Jan 12, 2022 ↗
Q1 2022
· target $71M
Filing details
HeadquartersSeattle, WAIndustryBiotech & Pharma (Pharmaceuticals)Incorporated2021SEC CIK0001903219Offerings on file3
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. Spot an error? Full methodology →